Lip Aging
Conditions
Interventions
Observation group (cross-sectional study) Phase I:None
Experimental Group (Young Group) Phase II:17 participants will be randomly selected to undergo an 8-week clinical trial. Usage: Apply the product evenly to lips 3 times daily: after breakfast, after l
Experimental group (elderly group) Phase II:17 participants will be randomly selected to undergo an 8-week clinical trial. Usage: Apply the product evenly to lips 3 times daily: after breakfast, after
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Subject who is Chinese female between 20~25 or 65~69 years old, in general good health; 2.Subject has signed an Informed Consent Form and willing to sign an Authorization Statement; 3.Subjects with normal to dry lip (self-perceived); 4.Subject who is dependable and able to follow directions; 5.Subject who has not used any lip product within 3 days prior to the study 6.Subject is a user of the test product category and/or an acceptor of the test product 7.Subject is neutral or favorable to the product fragrance; 8.Subject agrees not to expose herself to sun and to use protective measures to avoid excessive sun exposures (sunscreen, hat, umbrella as needed); 9.Subject who agrees not wear any other treatment other than the assigned test products and not wear new cosmetic (makeup) products to test area(lips), during the course of the study.
Exclusion criteria
Exclusion criteria: 1.Subject reports being pregnant or nursing; 2.Subject who is currently using, or has routinely used within two weeks prior to study initiation, any systemic or topical corticosteroids, vasoconstrictors, antibiotics, anti-inflammatory medications; 3.Subject has a history of chronic dermatologic, medical, and/or physical conditions, or presently has a dermatologic condition that, in the opinion of the physician(s)or the investigator, might interfere with the conduct of the study, interpretation of results, or increase the risk of adverse reactions (e.g. eczema, psoriasis, rosacea, suspicious lesion, severe acne, rash, broken skin, scar, tattoos, sunburn cold sores/fever blisters more than 2x/year, cracked lips, styes/chalazion more than 2x/year, seborrheic dermatitis, severe dandruff, or skin cancer); 4. Subject who has cold sores, cheilitis, habitual licking, irritation or other chronic medical conditions on the lips within the past 4 weeks; 5. Subject who has a history of adverse reactions to the same type of product as the investigated products; 6. Subject has participated in a clinical or cosmetic study within 1 month of study initiation; 7.Subject has participated in any investigational systemic drug study within two weeks of study initiation; 8. Subject had any facial, lip / perilabial medical treatments and surgery, such as facial peels, photo facials, laser treatment, dermabrasion, botulinum toxin (Botox®), injectable filler treatments, intense pulsed light (IPL), acid treatment, lip fillings, lip injections, lip piercings, lip tattoos, etc., which could influence the outcome of the study, in the past 6 months; 9.Subject with a condition or situation which, in the Investigators opinion, may put the subject at significant risk, may interfere the study results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lip Plumping;Lip lines; | — |
Countries
China
Contacts
Public ContactTan Yimei
Shanghai Skin Disease Hospital
Outcome results
None listed